Skip to main content

Muscarinic M1-Receptor-Antagonists in Health and Disease

  • Conference paper
Muscarinic Receptor Subtypes in the GI Tract
  • 84 Accesses

Abstract

Muscarinic antagonists are widely used in clinical medicine as inhibitors of secretory and motor functions of the gastrointestinal (GI) tract. Atropine as a potent muscarinic inhibitor produces considerable side effects on the heart, accommodation, and saliva secretion. Pirenzepine, a tricyclic compound with muscarinic-1 (M1)-receptor antagonist properties, varies in its affinity for the different subclasses of muscarinic receptors (Hammer et al. 1980). Besides a reduction in gastric volume secretion, there are contradictatory results as far as the effect on lower esophageal sphincter pressure (LESP) is concerned (Jaup et al. 1982; Malhotra et al. 1983). In accordance with the finding of various muscarinic receptors on smooth muscle cells and myenteric neurons within the GI tract (Goyal and Rattan 1978; Fox et al. 1983), a different effect on GI motility may be observed with a selective M1-antagonist, as compared with the less specific actions of atropine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aeberhard PF, Magnenat LD, Zimmerman WA (1982) Nervous control of migratory myoelectric complex of the small bowel. Am J Physiol 238: G 102–G 108.

    Google Scholar 

  • Baldi F, Ferrarini F, Cassan M et al. (1983) Pirenzepine inhibits prostigmine stimulated sigmoid motility in normal subjects. Gastroenterology 84: 1097 [abstr].

    Google Scholar 

  • Chierichetti SM, Conciato MG (1979) Die Behandlung des Ulcus duodeni und ventriculi mit Pirenzepin. In: Blum AL, Hammer R (eds) Die Behandlung des Ulcus pepticum mit Pirenzepin. Demeter Verlag, Gräfelfing, pp 178–184.

    Google Scholar 

  • Fox JET, Daniel EE, Jury J (1983) Evidence for a muscarinic brake activated by peptides in the canine small intestine. Gastroenterol Clin Biol 7: 616 (abstr).

    Google Scholar 

  • Goyal RK, Rattan S (1978) Neurohumoral, hormonal, and drug receptors for the lower esophageal sphincter. Gastroenterology 74: 598–618.

    PubMed  CAS  Google Scholar 

  • Hammer R, Berrie CP, Birdsall NJM et al. (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283: 90–92.

    Article  PubMed  CAS  Google Scholar 

  • Jaup BH, Abrahamsson H, Virtanen R et al. (1982) The effect of pirenzepine compared to atropine and 1-hyoscamine on esophageal peristaltic activity in man. Scand J Gastroenterol [Suppl] 68: 1–26.

    Google Scholar 

  • Lederer PC, Lux G (1983) Dünndarmmotilität. In: Wienbeck M, Lux G (eds) Gastrointestinale Motilität. Edition medizin, Weinheim, pp 65-74.

    Google Scholar 

  • Lux G, Lederer PC, Femppel J et al. (1980) Spontaneous and 13-NLE-motilin induced interdigestive motor activity of esophagus, stomach, and small intestine. In: Christensen J (ed) Gastrointestinal Motility. Raven, New York, pp 269–277.

    Google Scholar 

  • Lux G, Lederer PC, Ellermann A (1983) Manometrie und Elektromyographie im Rektosigmoidbereich. In: Wienbeck M, Lux G (eds) Gastrointestinale Motilität. Edition medizin, Weinheim, pp 91-104.

    Google Scholar 

  • Malhotra A, Patel GK, Texter EC et al. (1983) Pirenzepine a muscarinic-1 antagonist increases LES pressure 2-3 fold for a prolonged period. Gastroenterology 84:1238 [Abstr].

    Google Scholar 

  • Marik F, Code CF (1975) Control of the interdigestive myoelectric activity in dogs by the vagus nerves and pentagastrin. Gastroenterology 69: 387–395.

    PubMed  CAS  Google Scholar 

  • Narducci F, Bassotti G, Daniotti S et al. (1985) Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci 30:124–128.

    Article  PubMed  CAS  Google Scholar 

  • Stacher G, Steinringer H, Bauer P et al. (1979) Die Wirkung von intramuskularem Pirenzepin, Atropin und Placebo auf die mahlzeitstimulierte Motilität des Kolon. In: Blum Al, Hammer R (eds) Die Behandlung des Ulcus pepticum mit Pirenzepin. Demeter Verlag, Gräfelfing, pp 139–144.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lederer, P.C., Thiemann, R., Ellermann, A., Radeck, J., Lux, G. (1985). Muscarinic M1-Receptor-Antagonists in Health and Disease. In: Lux, G., Daniel, E.E. (eds) Muscarinic Receptor Subtypes in the GI Tract. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70668-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70668-4_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70670-7

  • Online ISBN: 978-3-642-70668-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics